Lei Fu

2.5k total citations
96 papers, 2.0k citations indexed

About

Lei Fu is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Lei Fu has authored 96 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 42 papers in Infectious Diseases and 40 papers in Epidemiology. Recurrent topics in Lei Fu's work include Tuberculosis Research and Epidemiology (38 papers), Cancer therapeutics and mechanisms (22 papers) and Mycobacterium research and diagnosis (20 papers). Lei Fu is often cited by papers focused on Tuberculosis Research and Epidemiology (38 papers), Cancer therapeutics and mechanisms (22 papers) and Mycobacterium research and diagnosis (20 papers). Lei Fu collaborates with scholars based in China, United States and United Kingdom. Lei Fu's co-authors include Yu Lu, Haihong Huang, Faxing Ding, Haitao Xie, Dali Yin, Shifang Peng, Bin Wang, Jian Xu, Bin Wang and Fadlo R. Khuri and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lei Fu

91 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lei Fu China 24 914 729 557 268 156 96 2.0k
Guofeng Zhu China 18 745 0.8× 821 1.1× 635 1.1× 13 0.0× 36 0.2× 36 1.6k
Luís A. Vale-Silva Portugal 25 469 0.5× 556 0.8× 432 0.8× 218 0.8× 52 0.3× 38 2.0k
Hongen Li China 19 442 0.5× 190 0.3× 82 0.1× 45 0.2× 38 0.2× 50 1.0k
Wen‐Chi Su Taiwan 20 533 0.6× 151 0.2× 426 0.8× 71 0.3× 70 0.4× 47 1.2k
Yuan Lu China 25 1.2k 1.3× 389 0.5× 197 0.4× 36 0.1× 272 1.7× 68 2.1k
Shunji Hayashi Japan 21 494 0.5× 287 0.4× 146 0.3× 48 0.2× 49 0.3× 95 2.4k
Hairong Huang China 23 628 0.7× 920 1.3× 659 1.2× 154 0.6× 173 1.1× 88 1.7k
Liem Nguyen United States 23 1.1k 1.2× 1.5k 2.0× 1.1k 2.0× 149 0.6× 16 0.1× 38 2.4k
Alexander P. Bryant United States 18 811 0.9× 301 0.4× 404 0.7× 59 0.2× 17 0.1× 20 1.8k

Countries citing papers authored by Lei Fu

Since Specialization
Citations

This map shows the geographic impact of Lei Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Fu more than expected).

Fields of papers citing papers by Lei Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Fu. The network helps show where Lei Fu may publish in the future.

Co-authorship network of co-authors of Lei Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Fu. A scholar is included among the top collaborators of Lei Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Fu. Lei Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jiang, Chuan, Zhenyu Xu, Jin-Qing Liu, et al.. (2025). Noninvasive diagnosis of significant liver fibrosis in patients with chronic hepatitis B using nomogram and machine learning models. Scientific Reports. 15(1). 571–571. 1 indexed citations
3.
Liu, Jin-Qing, Lu Yu, Xiaowei Ma, et al.. (2025). Clinical Characteristics, Radiological, and Outcomes of Mucormycosis: A 14‐Year Retrospective Study From Southern China. Mycoses. 68(9). e70110–e70110.
4.
Zhang, Wei, et al.. (2025). Cystathionine γ-lyase downregulation promotes liver injury and necroptosis through reprogramming of methionine cycle. Redox Report. 30(1). 2531650–2531650. 1 indexed citations
5.
Peng, Wenting, Huimin Gu, Keyu Chen, et al.. (2023). Tenofovir alafenamide versus entecavir for treating hepatitis B virus-related acute-on-chronic liver failure: real-world study. Frontiers in Microbiology. 14. 1185492–1185492. 9 indexed citations
6.
Zhang, Jinmin, et al.. (2023). Adaptability Analysis of Sentinel−1A and ALOS/PALSAR−2 in Landslide Detection in the Qinling-Daba Mountains. Applied Sciences. 13(21). 12080–12080. 1 indexed citations
7.
Peng, Wenting, Chuan Jiang, Keyu Chen, et al.. (2023). Tenofovir amibufenamide vs tenofovir alafenamide for treating chronic hepatitis B: A real-world study. World Journal of Gastroenterology. 29(44). 5907–5918. 7 indexed citations
8.
Li, Juyi, Xiaofang Liang, Xiufang Wang, et al.. (2023). A missense GDF5 variant causes brachydactyly type A1 and multiple‐synostoses syndrome 2. JOR Spine. 7(1). e1302–e1302.
9.
Zhang, Jian, Huiwen Wang, Wei Zhang, et al.. (2023). TRAF2 as a key candidate gene in clinical hepatitis B-associated liver fibrosis. Frontiers in Molecular Biosciences. 10. 1168250–1168250. 3 indexed citations
10.
Li, Peng, Lei Fu, Bin Wang, et al.. (2022). Solubility-driven optimization of benzothiopyranone salts leading to a preclinical candidate with improved pharmacokinetic properties and activity against Mycobacterium tuberculosis. European Journal of Medicinal Chemistry. 246. 114993–114993. 6 indexed citations
11.
12.
Li, Peng, Bin Wang, Lei Fu, et al.. (2021). Identification of novel benzothiopyranones with ester and amide motifs derived from active metabolite as promising leads against Mycobacterium tuberculosis. European Journal of Medicinal Chemistry. 222. 113603–113603. 10 indexed citations
13.
Li, Qian, et al.. (2021). Prognostic and immune infiltrates for the Chromobox (CBX) protein family in human pancreatic adenocarcinoma. Journal of Gastrointestinal Oncology. 12(5). 2310–2324. 8 indexed citations
14.
Wei, Guo, et al.. (2020). Blocking circ_0013912 Suppressed Cell Growth, Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells in vitro and in vivo Partially Through Sponging miR-7-5p. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Wang, Rong, Lei Fu, Jinbin Li, et al.. (2020). Microarray Analysis for Differentially Expressed Genes Between Stromal and Epithelial Cells in Development and Metastasis of Invasive Breast Cancer. Journal of Computational Biology. 27(12). 1631–1643. 11 indexed citations
16.
Chen, Xi, et al.. (2019). Evaluation of antituberculosis activities of 14 antituberculosis drugs in macrophage. 41(9). 993–998. 4 indexed citations
17.
Fu, Xiaoyu, et al.. (2019). Plasma miR-146a predicts serological conversion of hepatitis B e-antigen (HBeAg) in chronic hepatitis B patients treated with nucleotide analogs. Annals of Translational Medicine. 7(18). 449–449. 4 indexed citations
18.
Li, Hao, Xingxing Wang, Bin Wang, et al.. (2017). Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences. 114(19). 5023–5028. 122 indexed citations
19.
Fu, Lei, et al.. (2017). Effects of herbal cake-separated moxibustion on related receptors and hormones of HPA axis in rat model of functional dyspepsia with liver stagnation and spleen deficiency syndrome.. Zhonghua zhongyiyao zazhi. 32(1). 238–241. 1 indexed citations
20.
Fu, Lei, Young‐Ae Kim, Xuerong Wang, et al.. (2009). Perifosine Inhibits Mammalian Target of Rapamycin Signaling through Facilitating Degradation of Major Components in the mTOR Axis and Induces Autophagy. Cancer Research. 69(23). 8967–8976. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guofeng Zhu Breakdown of academic impact, for papers by Luís A. Vale-Silva Breakdown of academic impact, for papers by Hongen Li Breakdown of academic impact, for papers by Wen‐Chi Su Breakdown of academic impact, for papers by Yuan Lu Breakdown of academic impact, for papers by Shunji Hayashi Breakdown of academic impact, for papers by Hairong Huang Breakdown of academic impact, for papers by Liem Nguyen Breakdown of academic impact, for papers by Alexander P. Bryant
Rankless by CCL
2026